LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | CP724714 | 0.12 | uM | LJP5 | 72 | hr | 1334 | 3769 | 4033 | 0.9338 | 0.9146 |
BT-20 | CP724714 | 3.33 | uM | LJP5 | 72 | hr | 1334 | 3473 | 4033 | 0.8608 | 0.8197 |
BT-20 | CP724714 | 10 | uM | LJP5 | 72 | hr | 1334 | 2676 | 4033 | 0.6628 | 0.5422 |
BT-20 | Alvocidib | 0.12 | uM | LJP6 | 72 | hr | 1334 | 1583 | 3925 | 0.4035 | 0.1161 |
BT-20 | Alvocidib | 0.37 | uM | LJP6 | 72 | hr | 1334 | 746 | 3925 | 0.1901 | -0.3120 |
BT-20 | Seliciclib | 0.04 | uM | LJP5 | 72 | hr | 1334 | 4094 | 4033 | 1.0156 | 1.0199 |
BT-20 | Seliciclib | 0.12 | uM | LJP5 | 72 | hr | 1334 | 4007 | 4033 | 0.9941 | 0.9928 |
BT-20 | Seliciclib | 1.11 | uM | LJP5 | 72 | hr | 1334 | 3827 | 4033 | 0.9489 | 0.9352 |
BT-20 | Seliciclib | 3.33 | uM | LJP5 | 72 | hr | 1334 | 3442 | 4033 | 0.8529 | 0.8091 |
BT-20 | AT-7519 | 0.12 | uM | LJP6 | 72 | hr | 1334 | 3834 | 3925 | 0.9770 | 0.9701 |
BT-20 | AT-7519 | 0.37 | uM | LJP6 | 72 | hr | 1334 | 3020 | 3925 | 0.7695 | 0.6901 |
BT-20 | AT-7519 | 3.33 | uM | LJP6 | 72 | hr | 1334 | 350 | 3925 | 0.0894 | -0.5784 |
BT-20 | AT-7519 | 10 | uM | LJP6 | 72 | hr | 1334 | 285 | 3925 | 0.0728 | -0.6302 |
BT-20 | AZD7762 | 1.11 | uM | LJP6 | 72 | hr | 1334 | 2258 | 3925 | 0.5752 | 0.4018 |
BT-20 | AZD7762 | 3.33 | uM | LJP6 | 72 | hr | 1334 | 1438 | 3925 | 0.3665 | 0.0491 |
BT-20 | AZD8055 | 0.04 | uM | LJP6 | 72 | hr | 1334 | 2367 | 3925 | 0.6035 | 0.4440 |
BT-20 | AZD8055 | 0.12 | uM | LJP6 | 72 | hr | 1334 | 1948 | 3925 | 0.4964 | 0.2749 |
BT-20 | AZD8055 | 3.33 | uM | LJP6 | 72 | hr | 1334 | 1391 | 3925 | 0.3546 | 0.0263 |
BT-20 | AZD8055 | 10 | uM | LJP6 | 72 | hr | 1334 | 1052 | 3925 | 0.2681 | -0.1421 |
BT-20 | Sorafenib | 0.12 | uM | LJP6 | 72 | hr | 1334 | 3764 | 3925 | 0.9591 | 0.9471 |
BT-20 | Sorafenib | 0.37 | uM | LJP6 | 72 | hr | 1334 | 3601 | 3925 | 0.9175 | 0.8923 |
BT-20 | CP466722 | 0.12 | uM | LJP5 | 72 | hr | 1334 | 4171 | 4033 | 1.0341 | 1.0421 |
BT-20 | CP466722 | 0.37 | uM | LJP5 | 72 | hr | 1334 | 4028 | 4033 | 0.9991 | 0.9992 |
BT-20 | GW843682X | 0.12 | uM | LJP6 | 72 | hr | 1334 | 3380 | 3925 | 0.8613 | 0.8170 |
BT-20 | GW843682X | 0.04 | uM | LJP6 | 72 | hr | 1334 | 3587 | 3925 | 0.9141 | 0.8876 |